deltatrials
Terminated PHASE4 NCT00850460

Quality of Life in Patients With Statin-Associated Myopathy

Quality of Life and Metabolic Alterations in Patients With Statin-Associated Myopathy

Sponsor: Adelphi University

Conditions Statin Adverse Reaction
Interventions Placebo Statins
Updated 6 times since 2017 Last updated: Sep 21, 2016 Started: Feb 28, 2009 Primary completion: Feb 28, 2013 Completion: Feb 28, 2013

Listed as NCT00850460, this PHASE4 trial focuses on Statin Adverse Reaction and remains terminated or withdrawn. Sponsored by Adelphi University, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

  5. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE4

    First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Adelphi University
  • Cornell University
  • Rockefeller University
Data source: Rockefeller University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • New York, United States